A detailed history of Avantax Advisory Services, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 2,206 shares of CRL stock, worth $431,868. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,206
Previous 2,336 5.57%
Holding current value
$431,868
Previous $482,000 9.96%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$187.96 - $245.29 $24,434 - $31,887
-130 Reduced 5.57%
2,206 $434,000
Q2 2024

Aug 09, 2024

BUY
$206.39 - $268.73 $482,127 - $627,753
2,336 New
2,336 $482,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.96B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Avantax Advisory Services, Inc. Portfolio

Follow Avantax Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Advisory Services, Inc. with notifications on news.